tbResList Print — ITCs Isothiocyanates

Filters: qv=476, qv2=%, rfv=%

Product

ITCs Isothiocyanates
Description: <p><b>Isothiocyanates</b> - ITCs</p>

<p><b>Abbreviation:</b> ITCs</p>

<p><b>Type:</b> Natural-product compound class / organosulfur phytochemicals</p>

<p><b>Source:</b> Isothiocyanates are produced primarily from glucosinolates in cruciferous vegetables such as broccoli, broccoli sprouts, cabbage, kale, Brussels sprouts, watercress, mustard, and related Brassicaceae plants. Tissue disruption allows myrosinase to hydrolyze glucosinolates and generate corresponding isothiocyanates.</p>

<p><b>Major Members:</b> <br>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=156">Sulforaphane (SFN)</a>, <br>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=388">phenethyl isothiocyanate (PEITC)</a>, <br>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=530">benzyl isothiocyanate (BITC)</a>, <br>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=518"> Moringin (MIC-1)</a>, <br>
<a href="https://nestronics.ca/dbx/tbResList.php?qv=531">allyl isothiocyanate (AITC)</a>, <br>
and other structurally related isothiocyanates.</p>

<p><b>Function:</b> Isothiocyanates modulate cellular detoxification, oxidative-stress responses, inflammation, apoptosis, cell-cycle regulation, epigenetic signaling, and xenobiotic metabolism. Many ITCs activate NRF2-dependent cytoprotective pathways while also producing sufficient electrophilic and oxidative stress to inhibit cancer-cell growth.</p>

<p><b>Cancer:</b> Isothiocyanates generally exhibit anticancer activity in preclinical models through apoptosis ↑, cell-cycle arrest ↑, detoxification enzyme activity ↑, NRF2 signaling modulation, inflammatory signaling ↓, proliferation ↓, angiogenesis ↓, migration/invasion ↓, and modulation of epigenetic enzymes including HDACs. Effects vary substantially among individual ITCs and cancer types.</p>

<p><b>Alzheimer's Disease:</b> Selected isothiocyanates, particularly sulforaphane, show neuroprotective activity in experimental models through NRF2 activation, antioxidant defense ↑, neuroinflammation ↓, mitochondrial protection, and modulation of protein-clearance pathways. Evidence should generally be attributed to the specific isothiocyanate rather than assumed for the entire class.</p>

Pathway results for Effect on Cancer / Diseased Cells

NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   ARE↑, 1,   GPx4↓, 1,   GSH↓, 2,   HO-1↑, 2,   Iron↑, 1,   lipid-P↑, 1,   MDA↑, 1,   NQO1↑, 1,   NRF2↑, 5,   ROS↑, 8,   ROS↓, 1,   Trx↑, 2,   TrxR↑, 1,   TrxR1↑, 1,   xCT/SLC7A11↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC25↓, 1,   compI↓, 1,   compIII↓, 3,   ETC↓, 1,   OCR↓, 1,   OXPHOS↓, 2,   PDH↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC-α↓, 1,   ACC1↓, 1,   ACLY↓, 1,   FASN↓, 1,   Glycolysis↓, 1,   GSK‐3β↓, 1,   HK2↓, 1,   PDK1 / PDPK1↓, 1,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

APAF1↑, 1,   Apoptosis↑, 3,   BAX↑, 1,   Bcl-2↓, 1,   Bcl-xL↓, 1,   BIM↑, 1,   Casp↑, 1,   Ferroptosis↑, 1,   p38↓, 1,   survivin↓, 1,   TumCD↑, 1,   XIAP↓, 2,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   AKT1↓, 1,   EGFR↓, 1,   HER2/EBBR2↓, 1,   JAK2↓, 1,   mTOR↓, 3,   PI3K↓, 2,   PTEN↑, 1,   STAT3↓, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

cMyc↓, 2,   DNMT1↓, 1,   DNMT3B↓, 1,   DNMTs↓, 1,   FOXO1↓, 1,   FOXO3↓, 1,   ac‑H3↑, 1,   ac‑H4↑, 1,   HDAC↓, 4,   HDAC2↓, 1,   HDAC3↓, 3,   HDAC6↓, 1,   KLF4↓, 1,   miR-140↑, 1,   miR-200c↑, 1,   miR-21↓, 1,   miR-29b↓, 1,   OCT4↓, 2,   SOX2↓, 1,   tumCV↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↓, 1,   DNAdam⇅, 1,   DNAdam↑, 2,   hTERT/TERT↓, 1,   P53↑, 1,   Telomerase↓, 1,   p‑γH2AX↑, 1,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1,   CDK4↓, 1,   CDK6↓, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 1,   cycE/CCNE↓, 1,   Ki-67↓, 1,   P21↑, 1,   p27/CDKN1B↑, 1,   TumCCA↑, 7,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH1A1↓, 1,   BMI1↓, 1,   CSCs↓, 4,   HH↓, 1,   Ki-67↓, 1,   Nanog↓, 2,   NOTCH↓, 1,   NOTCH↑, 1,   NOTCH2↑, 1,   TumCG↓, 2,   TumCP↓, 2,   Wnt↓, 2,  

Migration(tgid=13) ⓘ

AP-1↓, 1,   Ca+2↑, 1,   E-cadherin↑, 2,   EMT↓, 3,   MMP2↓, 2,   MMP9↓, 1,   N-cadherin↓, 1,   Slug↓, 1,   Snail↓, 2,   TGF-β↓, 1,   TumCI↓, 3,   TumCMig↓, 1,   TumMeta↓, 2,   Twist↓, 1,   uPAR↓, 1,   Vim↓, 1,   Zeb1↓, 1,   α-SMA↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 4,   CD31/PECAM-1↓, 1,   Hif1a↓, 1,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

MMP↓, 3,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 1,   CXCR4↓, 2,   IL6↓, 1,   Inflam↓, 2,   NF-kB↓, 4,   NK cell↑, 1,   PSA↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 1,   SXR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 4,   ChemoSen?, 1,   ChemoSen↑, 5,   CYP1A1↓, 1,   CYP1A2↓, 1,   CYP1B1↓, 1,   CYP3A4↓, 1,   Dose↝, 1,   Dose?, 1,   P450↓, 1,   RadioS↑, 2,   selectivity↑, 2,   selectivity↝, 1,   Synergy↑, 15,  

Clinical Biomarkers(tgid=22) ⓘ

AR↓, 1,   EGFR↓, 1,   HER2/EBBR2↓, 1,   hTERT/TERT↓, 1,   IL6↓, 1,   Polyps↓, 1,   PSA↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 2,   chemoP↑, 1,   chemoPv↑, 3,   Risk↓, 3,   toxicity↓, 1,   TumVol↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   Bacteria↓, 4,   GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 1,  
Total Targets: 173

Pathway results for Effect on Normal Cells

Redox & Oxidative Stress(tgid=1) ⓘ

GPx↑, 1,   GSH↑, 1,   NRF2↑, 1,   ROS↓, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

LDL↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 1,   Bax:Bcl2↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

MAPK↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

HDAC?, 1,   other↝, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP70/HSPA5↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   CHIP↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

Imm↑, 1,   Inflam↓, 2,   NeuroI↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

AChE↓, 1,   BChE↓, 1,   BDNF↑, 1,  

Protein Aggregation(tgid=19) ⓘ

BACE/β-secretase↓, 1,   tau↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↑, 1,   BioAv↝, 1,   Dose↝, 1,   eff↑, 2,   Half-Life↝, 1,  

Clinical Biomarkers(tgid=22) ⓘ

TC↓, 1,   TG/TAG↓, 1,  

Functional Outcomes(tgid=23) ⓘ

chemoP↑, 1,   cognitive↑, 2,   memory↑, 1,   neuroP↑, 1,   RenoP↑, 1,   toxicity↓, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiViral↑, 1,   Bacteria↓, 1,   Inf↓, 1,  
Total Targets: 39

Research papers

Year Title Authors PMID Link Flag
2016Effects of Brassicaceae Isothiocyanates on Prostate CancerSilvia NovíoPMC6272898https://pmc.ncbi.nlm.nih.gov/articles/PMC6272898/0
2006Effect of Isothiocyanates on Nuclear Accumulation of NF-κB, Nrf2, and Thioredoxin in Caco-2 CellsJana Jakubíková—https://pubs.acs.org/jafcau/article-abstract/54/5/1656/3558744/Effect-of-Isothiocyanates-on-Nuclear-Accumulation?redirectedFrom=fulltext0
2026Isothiocyanates as Ferroptosis Inducers to Promote Cancer Cell DeathValentina CitiPMC13436285https://pmc.ncbi.nlm.nih.gov/articles/PMC13436285/0
2025Molecular Targets of Isothiocyanates in Cancer: Recent AdvancesParul GuptaPMC4122603https://pmc.ncbi.nlm.nih.gov/articles/PMC4122603/0
2025Isothiocyanates inhibit the cisplatin-induced apoptosis and inflammation in human kidney HEK-293 cellsHa-Rin MoonPMC13458007https://pmc.ncbi.nlm.nih.gov/articles/PMC13458007/0
2024Dietary isothiocyanates and anticancer agents: exploring synergism for improved cancer managementQi WangPMC11196812https://pmc.ncbi.nlm.nih.gov/articles/PMC11196812/0
2024The role of isothiocyanate-rich plants and supplements in neuropsychiatric disorders: a review and updateMonica RamakrishnanPMC11484503https://pmc.ncbi.nlm.nih.gov/articles/PMC11484503/0
2023Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and TherapyGuanqiong NaPMC9916827https://pmc.ncbi.nlm.nih.gov/articles/PMC9916827/0
2021Epigenetics/epigenomics and prevention of early stages of cancer by isothiocyanates ReviewRasika HudlikarPMC8044264https://pmc.ncbi.nlm.nih.gov/articles/PMC8044264/0
2019Isothiocyanates: translating the power of plants to peopleDushani L PalliyaguruPMC6226005https://pmc.ncbi.nlm.nih.gov/articles/PMC6226005/0
2016CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cellsKozue SakaoPMC4417382https://pmc.ncbi.nlm.nih.gov/articles/PMC4417382/0
2013Erucin and benzyl isothiocyanate suppress growth of late stage primary human ovarian carcinoma cells and telomerase activity in vitroEvelyn Lamy22949403https://pubmed.ncbi.nlm.nih.gov/22949403/0
2012Cancer chemoprevention with dietary isothiocyanates mature for clinical translational researchShivendra V SinghPMC3529556https://pmc.ncbi.nlm.nih.gov/articles/PMC3529556/0
2026An Epidemiological Study on the Effectiveness of Nasturtium Herb and Horseradish Root (Angocin®Anti-Infekt N) as well as Other Phytopharmaceuticals, Synthetic Products, and Antibiotics on the Course of Acute Upper Respiratory Tract Infection (aURTI)Nina KassnerPMC13113389https://pmc.ncbi.nlm.nih.gov/articles/PMC13113389/0